Spring regulatory agenda: What’s coming soon-ish from the FDA
The FDA’s lack of a permanent commissioner does not seem to be halting its progress to propose and finalize dozens of new regulations, with the latest batch covering everything from adverse event reporting to supplemental application submissions to annual reports for INDs.
Overall, FDA expects to release more than 40 new proposed regulations and finalize another 24 in the coming months and years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.